> INVESTORS   Overview   Corporate Structure   Corporate Governance   Company History   Annual General Meeting   Postal Ballot   Investor FAQs   Stock Info   Financial Results   Subsidiary Financials   Annual Report   Disclosure to Stock Exchange   Nomination form   Press Releases   Presentations   Analyst Coverage   Investor Contacts

Disclosure to Stock Exchange   December 2015 24 Dec  Press Release:   Biocon Introduces CIMIVIR-L™ for  Hepatitis-C in India 09 Dec  Press Release:   NeoBiocon Partners with Novartis to offer  Vildagliptin for Diabetics in UAE

January to July 2020  January to December 2019  January to December 2018  January to December 2017  January to December 2016  December 2015

Biocon Businesses Recommended sites Biocon on     Home About Us Investor Relations Media Relations Careers Site Map Contact Us Our Growth Accelerators Fact Sheet Branded Formulations Biopharmaceuticals Research Services Active Discovery Program ABLE Karnataka Vision Group on BT Syngene International Biocon Academy                   Report adverse event/side effects and product complaints               * Disclaimer            © 2018, Biocon. All Rights Reserved